Vernalis Share Discussion Threads

[imabastard] 22/4/2008 19:56

vw .... hope you're right .... I bought yesterday too ....

[vwrich] 22/4/2008 14:03

have started to open a large position here , i took 280 k yesterday but did not show on trades , will be adding at different stages , this has bottomed out for sure , have done well on eme lets hope that follows me here , from the research i have done and also my wife works in the pharma industry it looks good.

[thepinkpanther] 22/4/2008 11:26

just seen your note vwrich, although better late than never......

1v3 443,750 bid depth 11 v 468,155 depth 15, if u believe those
i rather play charts
in addition, two brokers have given these huge upside price targets from here!
circa 16 & 30p.......wow, one sniff of a bid, one stated!

[vwrich] 21/4/2008 15:56

level 2 anybody thx

[vwrich] 21/4/2008 15:04

good time to buy , should see this push up this week.

[imabastard] 21/4/2008 12:27

.... you could have been the 'mad professor' in a time warp .... glad you cleared up the huge confusion !!!!!

[fhmktg] 21/4/2008 12:24

Duh!!!
2008 of course!

[fhmktg] 21/4/2008 09:38

Fellner pulls of a deal as usual.
Back to the portfolio for success medium term.
Any likely winners there in the next year or so?
Just looked up the website
Mid 2007 looks significant with trial results due on V3381 for pain control,V10153 for stroke and a possible submission for special status with the FDA for V1512 for Parkinsons
Hold on to your hats!

[imabastard] 21/4/2008 09:03

.... could the chart pattern be the forming of a right breast ?

.... good news for this stock .... (not the breast .... the financing) ....

[amazon_woman] 21/4/2008 08:54

Not really but we hit this level in Feb so looks like a bounce off all time lows.

The spike in the middle makes the double bottom theory a bit skewed but at these levels and with the financing it seems a pretty safe time to buy. All IMO etc

AW

[rafieh] 21/4/2008 08:47

AW,
I agree. The very low sP was reflecting the ultimate market fear i.e. the company going bust because of liquidity drying up. That fear should be alleviated now.

By the way, is this a classic double bottom on the chart?

[amazon_woman] 21/4/2008 08:34

All quiet here, good news. Bought a few this morning.

AW

[johnswan193] 17/4/2008 10:09

I thought this would be a strong takeover target and didn't expect it to fall back to these levels. I think the timing is what is holding things up because of how tight things are with credit at the moment. I still think 5p-6p is as low as this will go this year, while the upside is huge.

[latifs100] 17/4/2008 09:45

will stop averaging down.. keeps on going down.. any ideas? sud be atkeover target?

[kenbachelor] 15/4/2008 16:34

Well I've never seen a trade of 17,000,000 shares on here before!

[quraishim] 09/4/2008 15:09

well oversold

[joeblogg1000] 08/4/2008 15:19

No it isn't. :((

[adgd2] 08/4/2008 07:40

Not looking good -


CHADDS FORD, PA, Apr 07, 2008 (MARKET WIRE via COMTEX News Network) -- Endo Pharmaceuticals Inc., a market leader in pain management and a wholly owned subsidiary of Endo Pharmaceuticals Holdings Inc. (NASDAQ: ENDP), today announced that it has notified the U.S. Food and Drug Administration (FDA) of the withdrawal of the supplemental new drug application (sNDA) without prejudice to refiling as afforded under 21 CFR 314.65 for FROVA(R) (frovatriptan succinate) 2.5 mg tablets. This sNDA was for the additional indication of FROVA for the short-term (six days per month) prevention of menstrual migraine. Endo is continuing to evaluate development opportunities for FROVA for this indication and other, related indications. FROVA is already approved and marketed for the acute treatment of migraine with or without aura in adults where a clear diagnosis of migraine has been established.

"The decision to withdraw the unapproved supplemental application was complex; however, after a lengthy and detailed evaluation of the points raised in the FDA 'not approvable' letter, we have determined the withdrawal to be the appropriate course of action at this time," said Dave Holveck, Endo President and Chief Executive Officer. "We appreciate the guidance from the FDA during the development program and its comprehensive review of the supplemental application."

[bountyhunter] 07/4/2008 18:02

Q, j, me as well :( Long term hold now !

[joeblogg1000] 07/4/2008 16:07

Q. There was concerted effort in papers, GSachs note to get this up to 15p and now done to this level. The directors, or atleast one of them holds a lot well above current price so lets hope the FDA review the appeal soon in our favour. I wonder how the sales are but we should have an update soon?

[quraishim] 07/4/2008 16:02

joeblogg still holding as i dont see any sense when i am £3k loss

[joeblogg1000] 07/4/2008 16:00

John. I hope so. Like Q. got sucked in and down about 10k having bought on the way up. G Sachs note not done any good.

[johnswan193] 07/4/2008 15:50

SP has not moved in a couple of weeks so support level appears to have been found. Still a takeover target and worth holding IMHO. DYOR.

[jarjar] 07/4/2008 15:28

where is this share price going ?
I know the arguments about the appeal etc
but in the meantime is there no limit to the drop
apart from zero perhaps ?